Work

Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity

Year: 2019
Type: review
Abstract: Tumor heterogeneity is the major cause of failure in cancer prognosis and prediction. Accurately detecting heterogeneity for the development of biomarkers and the detection of the clones resistant to therapy is one of the main goals of contemporary medicine. Metastases belong to the natural history of cancer. The present review gives an overview on the origin of tumor heterogeneity. Recent progress has made it possible to isolate and characterize circulating tumor cells (CTCs), which are the drivers of the disease between the primary sites and metastatic foci. The most recent methods for characterizing CTCs are summarized and we discuss the power of CTC profiling for analyzing tumor heterogeneity in early and advanced diseases.
Source: Theranostics
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $1,671
OpenAlex ID: W2940597085
FWCI: 1.625
Cites: 161
Cited by: 120
Related to: 9